Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
Blood|April 26, 2000
Thrombin activatable fibrinolysis inhibitor and the risk for deep vein thrombosisN H van Tilburg, F R Rosendaal, R M BertinaThrombosis and Haemostasis|April 30, 1976
Molecular variant of factor VIIE Briët, E A Loeliger, N H Van Tilburg, et al.British Journal of Haematology|November 1, 1982
Heterogeneity of haemophilia A: a study with three different antiseraH P Muller, N H van Tilburg, R M Bertina, et al.Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|April 1, 1993
Activated protein C accelerates clot lysis by virtue of its anticoagulant activityN J de Fouw, N H van Tilburg, F Haverkate, et al.The American Journal of Medicine|October 1, 1978
Acquired antithrombin III deficiency and thrombosis in the nephrotic syndromeR H Kauffmann, J J Veltkamp, N H Van Tilburg, et al.Thrombosis and Haemostasis|December 15, 1986
Immunoradiometric assays for human coagulation factor VII using polyclonal antibodies against the Ca(II)-dependent and Ca(II)-independent conformationV J Bom, N H van Tilburg, C Krommenhoek-van Es, et al.Blood|November 1, 1981
A monoclonal antibody to VIII:C produced by a mouse hybridomaH P Muller, N H van Tilburg, J Derks, et al.Clinica Chimica Acta; International Journal of Clinical Chemistry|October 23, 1980
Immunoradiometric assay of procoagulant factor VIII antigen (VIIICAG)H P Muller, N H van Tilburg, R M Bertina, et al.British Journal of Haematology|February 12, 2004
Association between thrombin activatable fibrinolysis inhibitor genotype and levels in plasma: comparison of different assaysA H C Guimarães, N H van Tilburg, H L Vos, et al.Biology of the Neonate|January 1, 1985
Coagulation factors in the premature infant born after about 32 weeks of gestationJ P Terwiel, J J Veltkamp, R M Bertina, et al.Pageof 2